Serum Apolipoprotein-A1 and Cholesterol Levels in Nigerian Children with Plasmodium falciparum Infection

Area of Science:

• Biochemistry
• Infectious Diseases
• Pediatrics

Background:

• Malaria, caused by Plasmodium falciparum, is a significant global health concern, especially in young children.
• Lipid metabolism and apolipoprotein-A1 play crucial roles in health and disease, but their specific alterations in pediatric malaria are not fully understood.

Purpose of the Study:

• To investigate the impact of Plasmodium falciparum malaria on serum apolipoprotein-A1 and cholesterol levels in children under five.
• To determine if apolipoprotein-A1 levels correlate with the severity of malaria infection in this age group.

Main Methods:

• A case-control study involving 255 children: 170 with P. falciparum malaria (85 uncomplicated, 85 complicated) and 85 healthy controls.
• Serum levels of apolipoprotein-A1, total cholesterol, HDL, LDL, and triglycerides were measured and compared using ANOVA and post hoc analyses.

Main Results:

• Children with malaria (both uncomplicated and complicated) exhibited significantly lower mean serum levels of apolipoprotein-A1, total cholesterol, and LDL compared to healthy controls.
• While both malaria groups showed reduced lipid levels, the reductions were more pronounced in children with complicated malaria.
• No significant difference in lipid levels was observed between the uncomplicated and complicated malaria groups themselves, but the severity of reduction was worse in complicated malaria.

Conclusions:

• Altered serum lipid profiles, characterized by reduced apolipoprotein-A1, are associated with complicated malaria in children.
• These findings suggest that apolipoprotein-A1 and lipid level alterations may hold diagnostic utility in managing pediatric malaria.